AHKSY News and Press, Asahi Kasei Corp ADR

Asahi Kasei’s newest global car user survey gives insights into the brand loyalty and buying behavior of car users in the four major automotive markets: Germany, the United States, China, and Japan. It also provides background information on technological reasons for consumers’ hesi...

Leveraging Microza™ expertise to enable lower energy consumption and higher water quality Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI (water for injection), a type of sterile water that is used for the preparation of injectio...

Following the first reported 100 mm diameter AlN in 2023, the company now announces improved wafer quality based on specification for UVC LEDs Crystal IS , an Asahi Kasei company, today announced the successful serial production of 100 mm diameter single-crystal aluminum nitride (Al...

Proof of concept for lithium-ion batteries with improved power output and service life The Japanese technology company Asahi Kasei has successfully achieved proof of concept (POC) of lithium-ion batteries (LIBs) using its proprietary high ionic conductive electrolyte 1 . This tech...

Robotics manufacturers developing the next generation of devices need precise torque control, compact system design, and parts that generate low heat. To meet these needs, Asahi Kasei Microdevices (AKM) has launched a new line of integrated circuits (ICs) offering advanced capabilities in a m...

Asahi Kasei Medical's U.S. subsidiary Bionova Scientific, a full-service biologics CDMO, has decided to launch a new business line providing services leveraging plasmid DNA, and establish a dedicated facility for this purpose in Texas, the U.S. This press release features multimedia. View the...

Door opener for compact, fast and reliable protection of e.g., on-board chargers or DC/DC converters for electric vehicles Asahi Kasei Microdevices Corporation (AKM) and Silicon Austria Labs GmbH (SAL), the European research center for electronics and software based systems research, ha...

2024-06-02 03:00:00 ET Summary Suzhou MediLink partners with BioNTech to use its antibody-drug conjugate platform, receiving an upfront payment of $25 million and up to $1.8 billion in milestones. Asahi Kasei offers $1.1 billion to acquire Calliditas Therapeutics, aiming to expand...

2024-05-28 13:35:36 ET More on Travere Therapeutics Travere Therapeutics, Inc. (TVTX) Q1 2024 Earnings Call Transcript Travere Therapeutics Q1 2024 Earnings Preview Travere, CSL win conditional nod for kidney disease therapy in EU Seeking Alpha’s Quant...

2024-05-28 10:20:20 ET Summary Asahi Kasei will acquire Calliditas Therapeutics AB (publ) for $1.1 billion, representing an 83% premium to the closing price on the Stockholm exchange and a 74% premium to the Nasdaq closing price. The primary asset of interest in the acquisition is...